Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Pneumonia, Pneumococcal

moxifloxacin has been researched along with Pneumonia, Pneumococcal in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's6 (54.55)29.6817
2010's4 (36.36)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drobot, EI; Kondrashova, NM; Lyapun, IN; Plekhova, NG; Somova, LM1
Berg, J; Gruber, AD; Gutbier, B; Hellwig, K; Hippenstiel, S; Hocke, AC; Kershaw, O; Mayer, K; Müller-Redetzky, HC; Neudecker, J; Opitz, B; Rückert, J; Suttorp, N; Wienhold, SM; Witzenrath, M1
Chen, HH; Chiu, CH; Li, HC; Su, LH1
Carbonnelle, S; De Bel, A; Dediste, A; Glupczynski, Y; Huang, TD; Jacobs, F; Jordens, P; Lismond, A; Schatt, P; Tulkens, PM; Van Bambeke, F; Verhaegen, J; Verschuren, F1
Bello, S; Torres, A1
Bergoin, E; Charles, PE; Chavanet, P; Croisier, D; Etienne, M; Lequeu, C; Piroth, L; Portier, H1
Bast, DJ; Bell, D; Chen, X; de Azavedo, JC; Dresser, L; Low, DE; Mandell, LA; Saskin, R; Yue, M1
Ambler, J; Choudhri, S; Fogarty, C; Haverstock, D; Herrington, J; Torres, A1
Aguilar, L; Alou, L; Cafini, F; Echeverría, O; Giménez, MJ; Pérez-Trallero, E; Prieto, J; Sevillano, D1
Lütticken, R; Reinert, RR; Schlaeger, JJ1
Arvis, P; Marel, M; Moita, J; Petitpretz, P; Urueta, J1

Reviews

1 review(s) available for moxifloxacin and Pneumonia, Pneumococcal

ArticleYear
Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia.
    International journal of clinical practice, 2005, Volume: 59, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Macrolides; Male; Middle Aged; Moxifloxacin; Penicillin Resistance; Pneumonia, Pneumococcal; Quinolines; Streptococcus pneumoniae; Treatment Outcome

2005

Trials

1 trial(s) available for moxifloxacin and Pneumonia, Pneumococcal

ArticleYear
Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults.
    Chest, 2001, Volume: 119, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Aza Compounds; Community-Acquired Infections; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pneumonia, Pneumococcal; Quinolines; Treatment Outcome

2001

Other Studies

9 other study(ies) available for moxifloxacin and Pneumonia, Pneumococcal

ArticleYear
Pathomorphosis of experimental infection in mice, infected by Streptococcus pneumoniae, under the effect of immunotropic drugs.
    Bulletin of experimental biology and medicine, 2013, Volume: 155, Issue:4

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Animals, Outbred Strains; Anti-Bacterial Agents; Aza Compounds; Community-Acquired Infections; Dietary Supplements; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluoroquinolones; Immunologic Factors; Interleukin-2; Lung; Mice; Moxifloxacin; Pneumonia, Pneumococcal; Quinolines; Spleen; Streptococcus pneumoniae

2013
Moxifloxacin is not anti-inflammatory in experimental pneumococcal pneumonia.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Female; Fluoroquinolones; Humans; Lung; Mice, Inbred C57BL; Moxifloxacin; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Treatment Outcome

2015
Fluoroquinolone-nonsusceptible Streptococcus pneumoniae isolates from a medical center in the pneumococcal conjugate vaccine era.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2017, Volume: 50, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Disk Diffusion Antimicrobial Tests; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Fluoroquinolones; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Multilocus Sequence Typing; Pneumonia, Pneumococcal; Prospective Studies; Serogroup; Streptococcus pneumoniae; Topoisomerase II Inhibitors; Vaccines, Conjugate; Young Adult

2017
Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Belgium; beta-Lactams; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Comorbidity; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pneumonia, Pneumococcal; Quinolines; Streptococcus pneumoniae; Vaccination; Young Adult

2012
[Pneumococcus and quinolone resistance].
    Archivos de bronconeumologia, 2003, Volume: 39, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Child, Preschool; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Multivariate Analysis; Mutation; Ofloxacin; Penicillin Resistance; Penicillins; Pneumococcal Infections; Pneumonia, Pneumococcal; Quinolines; Recurrence; Risk Factors; Streptococcus pneumoniae

2003
Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5

    Topics: Animals; Anti-Infective Agents; Area Under Curve; Aza Compounds; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Lung; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Ofloxacin; Pneumonia, Pneumococcal; Quinolines; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Spleen; Streptococcus pneumoniae

2004
Novel murine model of pneumococcal pneumonia: use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and levofloxacin.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Body Temperature; Colony Count, Microbial; Disease Models, Animal; Female; Fluoroquinolones; Levofloxacin; Lung; Mice; Moxifloxacin; Ofloxacin; Pneumonia, Pneumococcal; Quinolines; Skin Temperature

2004
A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:2

    Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mutation; Ofloxacin; Pneumonia, Pneumococcal; Quinolines; Serum Bactericidal Test; Streptococcus pneumoniae

2006
Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Germany; Humans; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Pneumonia, Pneumococcal; Quinolines; Streptococcus pneumoniae

1998